Le Lézard
Classified in: Health
Subjects: RCL, PSF

Food Recall Warning (Allergen) - Sherbon brand Falooda Drink - Mango recalled due to undeclared milk


OTTAWA, ON, Feb. 9, 2023 /CNW/ - Product photo is available: https://recalls-rappels.canada.ca/en/alert-recall/sherbon-brand-falooda-drink-mango-recalled-due-undeclared-milk

 

Summary

Affected products

Brand

Product

Size

UPC

Codes

Sherbon

Falooda Drink ?
Mango

290 ml

6 67064 00020 1

All codes where milk is
not declared on the label


Issue

The affected product is being recalled from the marketplace because it contains milk which is not declared on the label.

The recalled product has been sold in Alberta, Ontario, and Quebec.

What you should do

Learn more:

Background

This recall was triggered by the Canadian Food Inspection Agency's inspection activities.

There have been no reported reactions associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 17:03
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary...

at 16:42
Accelerate Diagnostics, Inc. today announced financial preliminary results for the first quarter ended March 31, 2024. "During the...

at 16:40
Johnson & Johnson will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman,...

at 16:37
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that it has set a record date of May 17, 2024 (the "Record Date") for the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary, Inhibrx...

at 16:35
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the quarter ended March...

at 16:35
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced new data from a study further confirming the performance of its DecisionDx-UM test as a robust independent predictor of...



News published on and distributed by: